Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production
Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest potency THCV cultivars available Organigram will launch new products in Canada containing THCV, a... | May 25, 2023